CAPS News Alert Capstone Therapeutics Corp (CAPS) 0.2650 09/27/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Capstone Therapeutics Corp (CAPS) 0.2650 $CAPS

Capstone Therapeutics Corp. Announces Digital Corporate Communication Channels
GlobeNewswire - Fri Sep 05, 12:09PM CDT
Capstone Therapeutics Corp. (OTCQB:CAPS) (the "Company" or "Capstone Therapeutics" , a clinical stage biotechnology company developing a family of new peptide drugs, announced today its suite of online corporate communication channels to maintain on-going direct communication with stakeholders. The Company has launched official portals on social media channels including Facebook, Twitter, Google+ and The Chairman's Blog.

Capstone Therapeutics, Inc. - "A New Class of Cardiovascular Drug"
ACCESSWIRE - Fri Sep 05, 7:48AM CDT
New York, NY / September 5, 2014 / Capstone Therapeutics (OTCQB: CAPS) today published a new blog post on The Chairman's Blog, written by the Company's Executive Chairman and Principal Executive Officer, Jock Holliman. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.

Capstone Therapeutics Announces Phase 1a Results for AEM-28 Showing Safety and Biomarker Efficacy Signals
GlobeNewswire - Tue Sep 02, 8:57AM CDT
Capstone Therapeutics (OTCQB:CAPS) ("the Company" and its joint venture affiliate, LipimetiX Development, LLC ("JV" , announced today the completion of dosing and patient follow-up for its investigational AEM-28 (Apo E mimetic peptide) Phase 1a human clinical trial in cholesterol and lipid reduction. The Medical Safety Committee, reviewing all safety-related aspects of the clinical trial, observed an acceptable safety profile. As a first-in-man study, the primary endpoint was safety; yet, biomarker efficacy measurements analyzing pharmacodynamics yielded trends favoring AEM-28 versus placebo in multiple cholesterol and lipid endpoints.

Capstone Therapeutics Will Provide an Operating Update and Announces Second Quarter 2014 Financial Results
GlobeNewswire - Thu Aug 14, 8:05AM CDT
Capstone Therapeutics (OTCQB:CAPS); (the "Company" , today will hold a conference call and webcast to provide an operating update and announced financial results for the second quarter 2014.

Capstone Therapeutics Announces Second Quarter 2014 Financial Results and Operating Update Conference Call
GlobeNewswire - Wed Aug 06, 9:00AM CDT
Capstone Therapeutics (OTCQB:CAPS); (the "Company" , will hold a conference call and webcast on Thursday, August 14, 2014 at 4:30 pm EDT. The call may be accessed at 877-303-2908 (U.S.), 408-427-3860 (outside U.S.); accompanying slides may be viewed by logging onto the Investors section of the Company's website, www.capstonethx.com. A replay will be available beginning August 14, 2014 at 7:30 pm EDT until midnight August 17, 2014, and may be accessed at 855-859-2056 (U.S.) or 404-537-3406 (outside U.S.) with conference ID 81563431.

Capstone Therapeutics Announces Operating Update Conference Call, Planned Initiation of AEM-28 Phase 1 Study and Fiscal Year 2013 Financial Results
GlobeNewswire - Thu Mar 27, 9:29AM CDT
Capstone Therapeutics (OTCQB:CAPS) ("the Company" and its joint venture affiliate, LipimetiX Development, LLC ("JV" , today will hold a conference call and webcast to provide an operating update, discuss the start of AEM-28 Phase 1 clinical studies and report financial results for the fiscal year 2013.

Capstone Therapeutics Announces Operating Update Conference Call
GlobeNewswire - Mon Mar 24, 1:30PM CDT
Capstone Therapeutics (OTCQB:CAPS); (the "Company" , will hold a conference call and webcast on Thursday, March 27, 2014 at 4:30 pm EDT. The call may be accessed at 877-303-2908 (U.S.), 408-427-3860 (outside U.S.); accompanying slides may be viewed by logging onto the Investors section of the Company's website, www.capstonethx.com. A replay will be available beginning March 27, 2014 at 7:30 pm EDT until midnight March 30, 2014, and may be accessed at 855-859-2056 (U.S.) or 404-537-3406 (outside U.S.) with conference ID 12618657.

Health Briefs TV to Feature QAL Medical
PRWeb - Thu Jan 16, 12:01PM CST
The producers of Health Briefs TV are pleased to announce that QAL Medical will be featured in an upcoming segment on topics, trends, and issues related to "Improving Therapy Outcomes through Effective Technology Solutions" as part of the show's "Healthcare Today" series.

OTC Daily Alert Stock Watch - Capstone Therapeutics (OTCQB: CAPS)
WorldStockWire - Thu Aug 15, 9:00PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com

Capstone Therapeutics to Hold Quarterly Operating Update Conference Call
GlobeNewswire - Wed Aug 07, 1:16PM CDT
Capstone Therapeutics (OTCQB:CAPS); (the "Company" , will hold a conference call and webcast on Wednesday, August 14, 2013 at 4:30 pm EDT. The call may be accessed at 877-303-2908 (U.S.), 408-427-3860 (outside U.S.); accompanying slides may be viewed by logging onto the Investors section of the Company's website, www.capstonethx.com. A replay will be available beginning August 14, 2013 at 7:30 pm EDT until midnight August 17, 2013 and may be accessed at 855-859-2056 (U.S.) or 404-537-3406 (outside U.S.) with conference ID 27383573.

Capstone Therapeutics Will Provide an Operating Update and Announces First Quarter 2013 Financial Results
GlobeNewswire - Wed May 15, 8:30AM CDT
Capstone Therapeutics (OTCQB:CAPS); (the "Company" , today will hold a conference call and webcast to provide an operating update and announced financial results for the first quarter 2013.

Capstone Therapeutics to Hold Operating Update Conference Call
GlobeNewswire - Wed May 08, 8:00AM CDT
Capstone Therapeutics (OTCQB:CAPS); (the "Company" , will hold a conference call and webcast on Wednesday, May 15, 2013 at 4:30 pm EDT. The call may be accessed at 877-303-2908 (U.S.), 408-427-3860 (outside U.S.); accompanying slides may be viewed by logging onto the Investors section of the Company's website, www.capstonethx.com. A replay will be available beginning May 15, 2013 at 7:30 pm EDT until midnight May 18, 2013 and may be accessed at 855-859-2056 (U.S.) or 404-537-3406 (outside U.S.) with conference ID 68894502.

Capstone Therapeutics Will Provide an Operating Update and Announces 2012 Financial Results
GlobeNewswire - Thu Mar 14, 7:15AM CDT
Capstone Therapeutics (OTCQB:CAPS); (the "Company" , today will hold a conference call and webcast to provide an operating update and 2012 financial results.

OTC Signal Daily Stock Watch - Capstone Therapeutics (CAPS)
WorldStockWire - Mon Dec 17, 10:45AM CST
OTC Signal tracks stocks daily and is pleased to offer its stock alerts. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Signal at the following: http://www.otcsignal.com




Scroll down for more posts ▼

Top 10 Most Recent News Articles

GFT's Banking Leader Tag Puts Execution Risks Into Focus

Updated Category News Views 82

A banking overhaul is where glossy slides go to die. That is why GFT Technologies being named a Leader in QKS Group's 2026 SPARK Matrix for Digital Banking Services deserves a little more attention than the usual analyst-firm trumpet blast. This is not a prize for making a pretty mobile app. The work described here runs through strategy, architecture, core-platform...

Continue Reading
A. O. Smith's Sustainability Scorecard Has Real Teeth

Updated Category News Views 51

Numbers finally showed up wearing work boots in A. O. Smith’s latest sustainability report. The company says it beat every one of its three environmental targets, and the gaps were not the sort of rounding-error victories corporate communications teams love to polish until they shine. For investors following NYSE:AOS, that deserves a look—not a standing ovation, but a...

Continue Reading
Century Complete Tests Conway Demand Near Myrtle Beach

Updated Category News Views 139

Ninety-four lots in Conway may not move Wall Street by themselves, but they can say plenty about the kind of buyer Century Communities is chasing. Century Complete is opening its model at Cates Bay Crossing on Nov. 21, 2026, with single-family homes starting in the $260s. In a housing market where affordability gets talked to death and rarely delivered cleanly, that...

Continue Reading
Alphabet Lawsuit Puts Gemini Delays Under a Microscope

Updated Category News Views 65

July’s twin punches to Alphabet shares were not the sort of wobble investors can casually shrug off. First came a report on July 16 that Google was months behind on Gemini 3.5 Pro, its flagship AI model, after disappointing results from updated training data. Then came the harder financial reality a week later: a much larger 2026 capital-spending plan, negative...

Continue Reading
RAN Rebound Gains Speed, but 2027 Still Looks Flat

Updated Category News Views 101

Radio gear finally caught a pulse in the third quarter, and that matters after more than two years of contraction. Dell’Oro Group says worldwide Radio Access Network revenue rose at a mid-single-digit year-over-year rate in 3Q 2026, the market’s strongest quarterly growth in nearly five years. That is better than expected, which is a welcome change in a telecom...

Continue Reading
Specialized Metal Makers Become the New M&A Prize Again

Updated Category News Views 5

A forgotten heat-treatment line can suddenly be worth more than a shiny new mill when buyers realize nobody can duplicate its certifications, workforce, and customer approvals overnight. That is the basic truth sitting underneath BGL's Nov. 19, 2026 assessment of the U.S. metals market. The easy headline is consolidation. The useful takeaway is much narrower: specialized...

Continue Reading
Rox Taps Dynamics 365 Without Forcing a CRM Reset Yet

Updated Category News Views 27

Enterprise software buyers hate renovations when a useful extension will do. Rox’s new integration with Microsoft Dynamics 365 Sales, announced November 19, 2026, is built around that unglamorous but very real fact. The company is not asking a Global 2000 sales organization to rip out its customer system, retrain everybody, and pray an AI layer somehow pays for the...

Continue Reading
RMT’s 12.4% Discount Still Demands a Much Harder Look

Updated Category News Views 58

A $1.84 gap is staring RMT shareholders right in the face. As of October 31, 2026, Royce Micro-Cap Trust carried a net asset value of $14.82 per share while the market price sat at $12.98. That is roughly a 12.4% discount to NAV, and closed-end fund investors should never wave off a spread like that with a lazy shrug. It may be opportunity. It may also be the market...

Continue Reading
&honey's U.S. Beauty Awards Sweep Puts Distribution in Focus

Updated Category News Views 83

Three glossy-magazine nods may sound fluffy, but shelf momentum is never entirely fluff. Japanese haircare brand &honey says its Deep Moist Shampoo, Treatment and Hair Oil each landed 2026 recognition from Marie Claire, ELLE and Allure. For a consumer brand trying to make an American habit out of a Japanese haircare ritual, that is the sort of validation worth...

Continue Reading
McDonald's Franchise Wage Suit Puts Compliance on Notice

Updated Category News Views 51

Payroll sloppiness can turn a cheap burger shift into an expensive courtroom problem fast. Zakay Law Group, APLC has filed a proposed class action in Alameda County Superior Court against a long list of McDonald's franchise-related entities, alleging workers were not paid all wages due under California law. The case, 26CV218760, is pending, not proven, and that...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights from the Global MOOC Conference on Future Education Trends

Updated Category News Views 197

The 2025 Global MOOC and Online Education Conference Overview The 2025 Global MOOC and Online Education Conference took place at the National Autonomous University of Mexico (UNAM) and focused on the theme of breaking boundaries to reshape futures in education. This event gathered educators and leaders in the field to discuss the future of online learning, with a...

Continue Reading
Truist Securities Predicts Growth Surge for Amazon Stock

Updated Category News Views 105

Amazon.com Inc (NASDAQ: AMZN) caught the attention of traders when Truist Securities boosted its price target from $230 to $265 back in early 2024. This wasn’t just a haphazard bump; they backed it with analysis that showed Amazon’s North American revenue holding steady, proving that consumers still love their Prime subscriptions and shopping sprees. What's fueling...

Continue Reading
Exploring the Rise of Probiotics in Animal Nutrition Market

Updated Category News Views 217

Understanding the Growth of Probiotics in Animal Feed As the demand for sustainable and antibiotic-free farming practices increases, the global probiotics in animal feed market is experiencing remarkable growth. Recent projections indicate that this market is expected to rise significantly, reflecting a shift in agricultural practices aimed at enhancing animal health and...

Continue Reading
Ascidian Therapeutics Announces Key Appointment to Advance Eyecare

Updated Category News Views 324

Key Appointment and New Advisory Board at Ascidian Therapeutics Ascidian Therapeutics, a pioneering biotechnology company focused on rewriting RNA to combat human diseases, has made a significant announcement. They have appointed Dr. Murray A. Abramson as Chief Development Officer (CDO) and created an Ophthalmology Clinical Advisory Board. This strategic move aims to...

Continue Reading
Waymo's Latest Robotaxi Innovation Marks a New Self-Driving Era

Updated Category News Views 375

Waymo's New Robotaxi Launches with Advanced Self-Driving Features Alphabet Inc.'s autonomous ride-hailing company, Waymo, has taken a significant step by introducing its latest Robotaxi equipped with sixth-generation self-driving technology. This advanced vehicle is now undergoing rigorous testing to ensure its readiness for the ever-competitive self-driving market....

Continue Reading